Revolution Medicines, Inc. R&D increased by 16.6% to $343.97M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 67.2%, from $205.75M to $343.97M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 51.6% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $45.94M | $46.47M | $53.68M | $56.49M | $61.00M | $69.46M | $66.13M | $68.95M | $97.98M | $107.74M | $148.48M | $118.02M | $134.93M | $151.75M | $187.52M | $205.75M | $224.13M | $262.51M | $294.94M | $343.97M |
| QoQ Change | — | +1.2% | +15.5% | +5.2% | +8.0% | +13.9% | -4.8% | +4.3% | +42.1% | +10.0% | +37.8% | -20.5% | +14.3% | +12.5% | +23.6% | +9.7% | +8.9% | +17.1% | +12.4% | +16.6% |
| YoY Change | — | — | — | — | +32.8% | +49.5% | +23.2% | +22.1% | +60.6% | +55.1% | +124.5% | +71.2% | +37.7% | +40.9% | +26.3% | +74.3% | +66.1% | +73.0% | +57.3% | +67.2% |
Range$45.94M – $343.97M
CAGR+52.8%
Avg YoY Growth+55.1%
Median YoY Growth+56.2%
Current Streak8 quarters growth
R&D at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s r&d?
- Revolution Medicines, Inc. (RVMD) reported r&d of $343.97M in Q1 2026.
- How has Revolution Medicines, Inc.'s r&d changed year-over-year?
- Revolution Medicines, Inc.'s r&d increased by 67.2% year-over-year, from $205.75M to $343.97M.
- What is the long-term trend for Revolution Medicines, Inc.'s r&d?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s r&d has grown at a 51.6% compound annual growth rate (CAGR), from $186.95M to $987.33M.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.